APA (7th ed.) Citation

J, M., G, M., J, N., R, I., A, N., O, A., . . . C, S. (2015). A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults. PloS one, 10(8), e0134287. https://doi.org/10.1371/journal.pone.0134287

Chicago Style (17th ed.) Citation

J, Mpendo, et al. "A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or Without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults." PloS One 10, no. 8 (2015): e0134287. https://doi.org/10.1371/journal.pone.0134287.

MLA (9th ed.) Citation

J, Mpendo, et al. "A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or Without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults." PloS One, vol. 10, no. 8, 2015, p. e0134287, https://doi.org/10.1371/journal.pone.0134287.